Areas of Focus
- Molecular Pathology of Tumors
- Tumor Microenvironment and Immunotherapy
- Lipid Metabolism in Renal Cancer
Work Experience
- 2020.09-present - Chongqing Medical University - Lecturer, Associate Researcher
Academic Background & Achievements
- 2011.09-2015.06 Dual Bachelor's in Biology/Finance: Southwest University
- 2015.09-2020.06 PhD in Biology: University of Chinese Academy of Sciences
Publications
- Resolvin D1 Attenuates Inflammation and Pelvic Pain Associated with EAP by Inhibiting Oxidative Stress and NLRP3 Inflammasome Activation via the Nrf2/HO-1 Pathway, Zhang J, Chen J, Jiang Q, et al, 2023
- A cancer associated fibroblasts-related six-gene panel for anti-PD-1 therapy in melanoma driven by weighted correlation network analysis and supervised machine learning, Tian L, Long F, Hao Y, et al, 2022
- m(6)A Regulator-Mediated Methylation Modification Patterns and Characteristics of Immunity in Blood Leukocytes of COVID-19 Patients, Qiu X, Hua X, Li Q, et al, 2021
- PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosis, Chen J, Hua X, Chen H, et al, 2021
- Integrated analysis of the functions of RNA binding proteins in clear cell renal cell carcinoma, Hua X, Chen J, Ge S, et al, 2021